BF
PFE icon

Blankinship & Foster’s Pfizer PFE Stock Holding History

Blankinship & Foster’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305K Hold
10,855
– – 0.07% 60
2025
Q4 		$270K Sell
10,855
-10
-0.1% -$252 0.06% 65
2025
Q3 		$277K Buy
10,865
+98
+0.9% +$2.42K 0.06% 62
2025
Q2 		$261K Buy
+10,767
New +$251K 0.06% 65
2022
Q3 		– Sell
-3,979
Closed -$209K – 54
2022
Q2 		$209K Sell
3,979
-212
-5% -$10.8K 0.1% 53
2022
Q1 		$217K Hold
4,191
– – 0.09% 51
2021
Q4 		$247K Buy
+4,191
New +$208K 0.09% 50

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Blankinship & Foster's PFE Position: Q1 2026 in Review

Blankinship & Foster held its Pfizer (PFE) position steady in Q1 2026 at 10,855 shares worth $305K. The position accounts for 0.07% of the portfolio, ranked #60.

Blankinship & Foster first reported a position in PFE in Q4 2021 and has held it in 7 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Blankinship & Foster held 10,855 shares of Pfizer worth $305K as of Q1 2026.
  • Blankinship & Foster left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.07% of Blankinship & Foster's portfolio in Q1 2026, its #60 holding.
  • Blankinship & Foster first reported a position in Pfizer in Q4 2021 and has held it in 7 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Blankinship & Foster's 13F filing for Q1 2026, filed 17 Apr 2026.